Inflammatory bowel diseases (IBD), such as ulcerative colitis and Crohn’s disease, have become a key focus for Pharma in recent years. Our scientists have extensive experience with efficacy, contractility, safety, ex vivo cultures, and ADME assays using intestinal tissue. We can access tissues from patients suffering from IBD, including Crohn’s disease and ulcerative colitis to investigate drug effects on intestinal permeability and inflammation.
Microscope histological image of IBD colitis intestine